Adelene Q. Perkins, EVP and Chief Business Officer at INFINITY PHARMACEUTICALS, INC. (INFI), bought 6,446 shares at $10.92 ($70K) on 2007-05-11, disclosed to the SEC on 2007-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.95 | 1,000 | $11K | 15.6% |
| 2 | $10.79 | 200 | $2K | 3.1% |
| 3 | $10.80 | 2,200 | $24K | 34.0% |
| 4 | $10.90 | 100 | $1K | 1.6% |
| 5 | $10.79 | 100 | $1K | 1.5% |
| 6 | $10.80 | 646 |
| $7K |
| 10.0% |
| 7 | $10.82 | 100 | $1K | 1.5% |
| 8 | $10.85 | 200 | $2K | 3.1% |
| 9 | $10.87 | 100 | $1K | 1.6% |
| 10 | $10.90 | 1,500 | $16K | 23.4% |
| 11 | $10.91 | 100 | $1K | 1.6% |
| 12 | $10.92 | 200 | $2K | 3.1% |
| Total | $10.86 avg | 6,446 | $70K | 100% |
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |